NAVB
Navidea Biopharmaceuticals Inc.
NAVB
NAVB
Delisted
NAVB was delisted on the 5th of October, 2023.
25 hedge funds and large institutions have $1.19M invested in Navidea Biopharmaceuticals Inc. in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 10 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
86% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 7
Holders
25
Holding in Top 10
–
Calls
$60K
Puts
$270K
Top Sellers
| 1 | -$51K | |
| 2 | -$37K | |
| 3 | -$33K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$32.7K |
| 5 |
Wolverine Trading
Chicago,
Illinois
|
-$13K |